A Policy Discussion for Advocates
Join us for a webinar on Wednesday, June 3 at 1:30 PM EST / 10:30 AM PST, as we discuss how a federal policy change will leave many patients facing higher out-of-pocket costs for their prescription medications. The recently released 2021 Notice of Benefit and Payment Parameters (NBPP) allows private health insurers to exclude certain co-pay assistance programs, such as cards and coupons, from counting toward deductibles and out-of-pocket maximums. As a result, patients will no longer be able to rely on these critical programs and face increased costs.
Federal health policy and advocacy expert Carl Schmid, Executive Director of the HIV + Hepatitis Policy Institute, will provide an overview of the NBPP rule change and key insights into the impact it will have on patients with chronic disease. During the webinar, we will discuss ways to blunt the impact and provide you with the knowledge and tools needed to advocate on behalf of patients in the chronic disease community.
Tune in to learn more about:
- The vital importance of co-pay assistance to keep medications affordable
- Co-pay accumulators and how they work
- Why this change to the NBPP is harmful for patients
- What CCPA is doing to advocate for patient rights and patient access
- How your organization can help keep prescription medicine affordable